المؤلفون: Drooger, Jan C., Akdeniz, Delal, Pignol, Jean-Philippe, Koppert, Linetta B., McCool, Danielle, Seynaeve, Caroline M., Hooning, Maartje J., Jager, Agnes, Leerstoel Heijden, Methodology and statistics for the behavioural and social sciences

المساهمون: Medical Oncology, Radiotherapy, Surgery, Leerstoel Heijden, Methodology and statistics for the behavioural and social sciences

المصدر: Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 154(1), 171-180. Springer New York
Breast Cancer Research and Treatment, 154(1), 171. Springer New York LLC

مصطلحات موضوعية: Oncology, Cancer Research, age distribution, Epidemiology, medicine.medical_treatment, retrospective study, cancer risk, primary tumor, distant metastasis, Risk Factors, middle aged, Breast-conserving surgery, tumor suppressor gene, cancer survival, risk reduction, Risk-reducing mastectomy, partial mastectomy, BRCA1 Protein, cancer adjuvant therapy, adult, Hazard ratio, BRCA mutation, article, mastectomy, Neoplasms, Second Primary, cohort analysis, female, priority journal, medical decision making, Mastectomy, mutational analysis, onset age, survival rate, medicine.medical_specialty, Breast Neoplasms, malignant neoplasm, Breast cancer, breast cancer, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, cancer radiotherapy, follow up, controlled study, human, contralateral risk reducing mastectomy, survival time, Survival rate, outcome assessment, Aged, Proportional Hazards Models, BRCA2 Protein, Radiotherapy, business.industry, high risk population, Retrospective cohort study, medicine.disease, heterozygote, major clinical study, Radiation therapy, cancer recurrence, Contralateral breast cancer, Mutation, Radiotherapy, Adjuvant, business

وصف الملف: application/pdf; image/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14cd7089cea86420ee5493bb5690037eTest
https://hdl.handle.net/1874/378711Test

المؤلفون: Giardiello, Daniele, Steyerberg, Ewout W, Hauptmann, Michael, Adank, Muriel A, Akdeniz, Delal, Blomqvist, Carl, Bojesen, Stig E, Bolla, Manjeet K, Brinkhuis, Mariël, Chang-Claude, Jenny, Czene, Kamila, Devilee, Peter, Dunning, Alison M, Easton, Douglas F, Eccles, Diana M, Fasching, Peter A, Figueroa, Jonine, Flyger, Henrik, García-Closas, Montserrat, Haeberle, Lothar, Haiman, Christopher A, Hall, Per, Hamann, Ute, Hopper, John L, Jager, Agnes, Jakubowska, Anna, Jung, Audrey, Keeman, Renske, Kramer, Iris, Lambrechts, Diether, Le Marchand, Loic, Lindblom, Annika, Lubiński, Jan, Manoochehri, Mehdi, Mariani, Luigi, Nevanlinna, Heli, Oldenburg, Hester SA, Pelders, Saskia, Pharoah, Paul DP, Shah, Mitul, Siesling, Sabine, Smit, Vincent THBM, Southey, Melissa C, Tapper, William J, Tollenaar, Rob AEM, Van Den Broek, Alexandra J, Van Deurzen, Carolien HM, Van Leeuwen, Flora E, Van Ongeval, Chantal, Van't Veer, Laura J, Wang, Qin, Wendt, Camilla, Westenend, Pieter J, Hooning, Maartje J, Schmidt, Marjanka K

مصطلحات موضوعية: BRCA2 Protein, BRCA1 Protein, BRCA mutation carriers, Clinical Decision-Making, Disease Management, Breast Neoplasms, Neoplasms, Second Primary, Prognosis, Risk Assessment, 3. Good health, Risk Factors, Contralateral breast cancer, Area Under Curve, Humans, Female, Disease Susceptibility, 10. No inequality, Germ-Line Mutation, Risk prediction model, Netherlands, Proportional Hazards Models

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4e4814aa64cf985e8ac7649bde4187a5Test